142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

300823
US drug policy: A dynamic system of change in a multi-level environment

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

Yvonne Terry-McElrath, MSA , Institute for Social Research, University of Michigan, Ann Arbor, MI
Duane C. McBride, PhD , Behavioral Science Department, Andrews University, Berrien Springs, MI
Issues: A prime example of how where one lives impacts health and health care access can be seen in drug policy: geographical location currently determines the difference between punitive deterrence, a public health approach with treatment access, or (for some substances), open adult use. An incomplete understanding of the variance in drug policy at local, state and national levels limits the effectiveness of advocacy efforts to reduce the costs and harmful consequences resulting from the use and/or abuse of alcohol, tobacco, and other drugs.

Description: This paper uses ecological systems theory and primary data to present how drug policy has been and continues to be developed and applied in the US.

Lessons Learned: Macro-level US drug policy should be understood as two connected yet separate policy levels: federal and state. The mezzo level includes systems and institutions such as public health, treatment and criminal justice. The micro level includes non-systems-level collective advocacy (organizing ballot initiatives and referendums), as well as individual attitudes and behaviors of abstainers, users, substance abuse treatment participants, etc. Each level exerts direct and reciprocal influences within and across other levels.

Recommendations: Recognition and understanding of the multi-level nature of drug policy in the US can strengthen efforts to bring levels of system balance to the very complex recursive US drug policy continuum. There are many potential levers of change that too often have been under-utilized, including recognition of the active role of systems/institutions—such as public health—in policy implementation.

Learning Areas:

Advocacy for health and health education
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Explain the multi-level nature of drug policy in the US and how it impacts access to needed services. Identify drug policy participants in specific geographic locations to improve the public’s health. Describe ways in which various drug policy participants may be able to strengthen the drug policy environment.

Keyword(s): Policy/Policy Development, Drug Abuse

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have participated in substance-related policy research for the last 15 years.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.